HIV-infected individuals who use alcohol and other drugs, and virologic suppression

References

• Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381. PMID: 12047736 doi: 10.1007/s11606-002-0044-3
   PubMed Web of Science ®Google Scholar
• Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010). A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug and Alcohol Dependence, 112, 178–193. doi: 10.1016/j.drugalcdep.2010.06.014
   PubMed Web of Science ®Google Scholar
• Babor, T. F., Stephens, R. S., & Marlatt, G. A. (1987). Verbal report methods in clinical research on alcoholism: Response bias and its minimization. Journal of Studies on Alcohol, 48(5), 410–424. PMID: 3312821 doi: 10.15288/jsa.1987.48.410
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43(7), 939–941. PMID: 16941380 doi: 10.1086/507526
   PubMed Web of Science ®Google Scholar
• Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182. PMID: 3806354 doi: 10.1037/0022-3514.51.6.1173
   PubMed Web of Science ®Google Scholar
• Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, B., & Campa, A. (2009). Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50, 93–99. doi: 10.1097/QAI.0b013e3181900129
   PubMed Web of Science ®Google Scholar
• Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, J. B., & Campa, A. (2010). Alcohol use accelerates HIV disease progression. AIDS Research and Human Retroviruses, 26(5), 511–518. doi: 10.1089/aid.2009.0211
   PubMed Web of Science ®Google Scholar
• Bonn-Miller, M. O., Oser, M. L., Bucossi, M. M., & Trafton, J. A. (2014). Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. Journal of Behavioral Medicine, 37(1), 1–10. doi: 10.1007/s10865-012-9458-5
   PubMed Web of Science ®Google Scholar
• Bouhnik, A. D., Preau, M., Vincent, E., Carrieri, M. P., Gallais, H., Lepeu, G., … Spire, B. (2005). Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antiviral Therapy, 10(1), 53–61. PMID: 15751763
   PubMed Web of Science ®Google Scholar
• Carrico, A. W. (2011). Substance use and HIV disease progression in the HAART era: Implications for the primary prevention of HIV. Life Sciences, 88(21-22), 940–947. doi: 10.1016/j.lfs.2010.10.002
   PubMed Web of Science ®Google Scholar
• Carrieri, M. P., Moatti, J. P., Vlahov, D., Obadia, Y., Reynaud-Maurupt, C., & Chesney, M. (1999). Access to antiretroviral treatment among French HIV-infected injection drug users: The influence of continued drug use. MANIF 2000 study group. Journal of Epidemiology & Community Health, 53(1), 4–8. PMID: 10326045 doi: 10.1136/jech.53.1.4
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., & Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. JAMA, 280(6), 544–546. PMID: 9707145 doi: 10.1001/jama.280.6.544
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493–505. doi: 10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Costagliola, D., Ledergerber, B., Torti, C., van Sighem, A., Podzamczer, D., Mocroft, A., … Castagna, A. (2013). Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes. Journal of Infectious Diseases, 207(5), 759–767. doi: 10.1093/infdis/jis752
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. (2016). Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved AIDSinfo June 19, 2016, from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
   Google Scholar
• Egger, M., May, M., Chene, G., Phillips, A. N., Ledergerber, B., Dabis, F., & Sterne, J. A. (2002). Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. The Lancet, 360(9327), 119–129. PMID: 12126821 doi: 10.1016/S0140-6736(02)09411-4
   PubMed Web of Science ®Google Scholar
• Ellis, R., Childres, M., Cherner, M., Lazaretto, D., Letendre, S., & Grant, I. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. The Journal of Infectious Diseases, 188, 1820–1826. doi: 10.1086/379894
   PubMed Web of Science ®Google Scholar
• Friedman, H., Pross, S., & Klein, T. W. (2006). Addictive drugs and their relationship with infectious diseases. FEMS. FEMS Immunology & Medical Microbiology, 47(3), 330–342. doi: 10.1111/j.1574-695X.2006.00097.x
   PubMedGoogle Scholar
• Gonzalez, A., Barinas, J., & O'Cleirigh, C. (2011). Substance use: Impact on adherence and HIV medical treatment. Current HIV/AIDS Reports, 8(4), 223–234. doi: 10.1007/s11904-011-0093-5
   PubMedGoogle Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., … Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185–194. doi: 10.1007/s10461-006-9152-0
   PubMed Web of Science ®Google Scholar
• Kelly, J. D., Hubenthal, E. A., Lurton, G., Empson, S. F., Barrie, M. B., Kargbo, B., … Giordano, T. P. (2013). Multiple self-report measures of antiretroviral adherence correlated in Sierra Leone, but did they agree? International Journal of STD & AIDS, 24(12), 931–937. doi: 10.1177/0956462413487327
   PubMed Web of Science ®Google Scholar
• Kipp, A. M., Desruisseau, A. J., & Qian, H. Z. (2011). Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. Journal of Substance Abuse Treatment, 40(4), 386–396. doi: 10.1016/j.jsat.2011.01.001
   PubMed Web of Science ®Google Scholar
• Knowlton, A., Arnsten, J., Eldred, L., Wilkinson, J., Gourevitch, M., Shade, S., … Purcell, D. (2006). Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(4), 486–492. doi: 10.1097/01.qai.0000186392.26334.e3
   PubMed Web of Science ®Google Scholar
• Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdottir, T. B., Richter, C., … Nieuwkerk, P. T. (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Medicine, 12, e438. doi:10.1186/PREACCEPT-1453408941291432 doi: 10.1186/s12916-014-0142-1
   Web of Science ®Google Scholar
• Larsen, M. V., Omland, L. H., Gerstoft, J., Roge, B. T., Larsen, C. S., Pedersen, G., … Kronborg, G. (2010). Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1 infected patients: A nationwide population-based cohort study. Scandinavian Journal of Infectious Diseases, 42(11-12), 917–923. doi: 10.3109/00365548.2010.511258
   PubMed Web of Science ®Google Scholar
• Leonhard, C., Mulvey, K., Gastfriend, D. R., & Shwartz, M. (2000). The addiction severity index: A field study of internal consistency and validity. Journal of Substance Abuse Treatment, 18(2), 129–135. PMID: 10716096 doi: 10.1016/S0740-5472(99)00025-2
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Chaisson, R. E., & Moore, R. D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131(2), 81–87. PMID: 10419445 doi: 10.7326/0003-4819-131-2-199907200-00002
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 27(3), 251–259. PMID: 11464144 doi: 10.1097/00042560-200107010-00006
   PubMed Web of Science ®Google Scholar
• Malta, M., Magnanini, M. M., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS and Behavior, 14(4), 731–747. doi: 10.1007/s10461-008-9489-7
   PubMed Web of Science ®Google Scholar
• Mann, B., Milloy, M. J., Kerr, T., Zhang, R., Montaner, J., & Wood, E. (2012). Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users. HIV Medicine, 13(10), 596–601. doi: 10.1111/j.1468-1293.2012.01021.x
   PubMed Web of Science ®Google Scholar
• Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., … Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet, 372(9651), 1733–1745. doi: 10.1016/S0140-6736(08)61311-2
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. The Journal of Nervous and Mental Disease, 168(1), 26–33. PMID: 7351540 doi: 10.1097/00005053-198001000-00006
   PubMed Web of Science ®Google Scholar
• Moore, D. J., Blackstone, K., Woods, S. P., Ellis, R. J., Atkinson, J. H., Heaton, R. K., & Grant, I. (2012). Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care, 24(12), 1504–1513. doi: 10.1080/09540121.2012.672718
   PubMed Web of Science ®Google Scholar
• Mugavero, M. J., Amico, K. R., Westfall, A. O., Crane, H. M., Zinski, A., Willig, J. H., … Saag, M. S. (2012). Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59(1), 86–93. doi: 10.1097/QAI.0b013e318236f7d2
   PubMed Web of Science ®Google Scholar
• Palepu, A., Tyndall, M. W., Chan, K., Wood, E., Montaner, J. S., & Hogg, R. S. (2004). Initiating highly active antiretroviral therapy and continuity of HIV care: The impact of incarceration and prison release on adherence and HIV treatment outcomes. Antiviral. Therapeutic(s), 9(5), 713–719. PMID: 15535408.
   PubMed Web of Science ®Google Scholar
• Palepu, A., Tyndall, M. W., Joy, R., Kerr, T., Wood, E., Press, N., … Montaner, J. S. (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence, 84(2), 188–194. doi: 10.1016/j.drugalcdep.2006.02.003
   PubMed Web of Science ®Google Scholar
• Palepu, A., Tyndall, M., Yip, B., O’shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2003). Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. JAIDS Journal of Acquired Immune Deficiency Syndromes, 32(5), 522–526. PMID: 12679704 doi: 10.1097/00126334-200304150-00009
   PubMed Web of Science ®Google Scholar
• Poundstone, K. E., Chaisson, R. E., & Moore, R. D. (2001). Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS (London, England), 15(9), 1115–1123. PMID: 11416713 doi: 10.1097/00002030-200106150-00006
   PubMed Web of Science ®Google Scholar
• Purcell, D. W., Parsons, J. T., Halkitis, P. N., Mizuno, Y., & Woods, W. J. (2001). Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. Journal of Substance Abuse, 13(1-2), 185–200. PMID: 11547619 doi: 10.1016/S0899-3289(01)00072-4
   PubMedGoogle Scholar
• Ribaudo, H. (2009). Virologic failure endpoint definition in clinical trials: Is using HIV-1 RNA threshold <200 copies/mL better than <50 copies/mL? An analysis of ACTG studies. Paper presented at: 16th conference on retroviruses and opportunistic infection, Montreal, Canada.
   Google Scholar
• Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., … Dunbar, G. C. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(20), 22–33. quiz 34-57. PMID: 9881538
   PubMed Web of Science ®Google Scholar
• Sobell, L. C., Maisto, S. A., Sobell, M. B., & Cooper, A. M. (1979). Reliability of alcohol abusers’ self-reports of drinking behavior. Behaviour Research and Therapy, 17(2), 157–160. PMID: 426744 doi: 10.1016/0005-7967(79)90025-1
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O’shaughnessy, M. V., Montaner, J. S., … Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA, 280(6), 547–549. PMID: 9707146 doi: 10.1001/jama.280.6.547
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 national survey on drug use and health: Summary of national findings, NSUDH series H-48, HHS publication No. (SMA) 14-4863. Rockville, MD: Author. Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2010). The NSDUH report: HIV/AIDS and substance use. Rockville, MD. Retrieved from http://www.samhsa.gov/sites/default/files/hiv-aids-and-substance-use.pdf
   Google Scholar
• Thiebaut, R., Morlat, P., Jacqmin-Gadda, H., Neau, D., Mercie, P., Dabis, F., & Chene, G. (2000). Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidemiologie du SIDA en aquitaine (GECSA). AIDS (London, England), 14(8), 971–978. PMID: 10853978. doi: 10.1097/00002030-200005260-00008
   PubMed Web of Science ®Google Scholar
• Tran, B. X., Nguyen, L. T., Do, C. D., Nguyen, Q. L., & Maher, R. M. (2014). Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS. BMC Public Health, 14, 1369. doi: 10.1186/1471-2458-14-27
   Web of Science ®Google Scholar
• Ustinov, A., Suvorova, A., Belyakov, A., Makhamatova, A., Levina, O., Krupitsky, E., … Heimer, R. (2016). Psychiatric distress, drug use and HIV viral load suppression in russia. AIDS and Behavior, 20(8), 1603–1608. doi: 10.1007/s10461-016-1297-x
   PubMed Web of Science ®Google Scholar
• Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS (London, England), 16(2), 269–277. PMID: 11807312 doi: 10.1097/00002030-200201250-00017
   PubMed Web of Science ®Google Scholar
• Weber, R., Huber, M., Rickenbach, M., Furrer, H., Elzi, L., Hirschel, B., … Ledergerber, B. (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: The Swiss HIV cohort study. HIV Medicine, 10(7), 407–416. doi: 10.1111/j.1468-1293.2009.00701.x
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Retrieved from http://www.who.int/hiv/pub/arv/summary-recommendations.pdf
   Google Scholar
• Zanis, D. A., McLellan, A. T., Cnaan, R. A., & Randall, M. (1994). Reliability and validity of the addiction severity index with a homeless sample. Journal of Substance Abuse Treatment, 11(6), 541–548. PMID: 7884837 doi: 10.1016/0740-5472(94)90005-1
   PubMed Web of Science ®Google Scholar